化学名称: (2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-((S)-3-(((1R,2S,4S,5S,7R)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl)oxy)-3-oxo-2-phenylpropoxy)tetrahydro-2H-pyran-2-carboxylic acid
微笑: CN1[C@@](C2)([H])[C@@]3([H])[C@@]([C@]1([H])C[C@@H]2OC([C@@H](C4=CC=CC=C4)CO[C@@H]([C@@H]([C@H]5O)O)O[C@@H]([C@H]5O)C(O)=O)=O)([H])O3
印地语: InChI=1S/C21H30NO4.BrH/c1-3-4-10-22(2)17-11-15(12-18(22)20-19(17)26-20)25-21(24)16(13-23)14-8-6-5-7-9-14;/h5-9,15-20,23H,3-4,10-13H2,1-2H3;1H/q+1;/p-1/t15-,16-,17-,18+,19-,20+,22-;/m1./s1
LC-MS as a Stability-Indicating Method for Analysis of Hyoscine N-Butyl Bromide under Stress Degradation Conditions with Identification of Degradation Products
Nouruddin W Ali , Mohammed Gamal1 * and Mohammed Abdelkawy
Ali et al., Pharm Anal Acta 2013, S7
Simultaneous determination of hyoscine N-butyl bromide and paracetamol in their binary mixture by RP-HPLC method
Nouruddin W. Ali Mohammed Gamal ,Mohammed Abdelkawy
Arabian Journal of Chemistry Volume 10, Supplement 2, May 2017, Pages S1868-S1874
The effect of hyoscine butylbromide in shortening the first stage of labor: A double blind, randomized, controlled, clinical trial
Nourah H Al Qahtani1 and Fatma Al Hajeri2
Ther Clin Risk Manag. 2011; 7: 495–500.